88 results
Page 4 of 5
8-K
v31 0py1ak
16 Oct 15
Regulation FD Disclosure
12:00am
8-K
EX-99.1
v4vw53t3 ovfgm
8 Apr 14
Alkermes Announces Positive Topline Results from Pivotal Phase 3 Study of Aripiprazole Lauroxil for Treatment of Schizophrenia
12:00am
10-KT
yacly0dnztzych
27 Feb 14
Annual report (with FYE transition)
12:00am
8-K
EX-99.1
gcfb5y h3m3
13 Jan 14
Entry into a Material Definitive Agreement
12:00am
424B5
y4brp8l
13 Jan 14
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
k10hq
25 Sep 12
Alkermes PLC Closes Debt Refinancing, Lowering Interest Rate and Reducing Principal Amount
12:00am
10-K
py6fm8d8o f986xyfmd
18 May 12
Annual report
12:00am
424B3
9xjsl ttg90mf5hm1
8 Mar 12
Prospectus supplement
12:00am
8-K
EX-99.1
c7vtazumc
8 Mar 12
Alkermes PLC Prices Secondary Offering of 21,000,000 Ordinary Shares Held by Elan
12:00am
424B3
oajbs313i71hv7
8 Mar 12
Prospectus supplement
12:00am
8-K
EX-99.1
b67derqejd qaa
7 Mar 12
Alkermes PLC Announces a Secondary Offering of 13,900,000 Ordinary Shares Held by Elan
12:00am